SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-012876
Filing Date
2023-04-14
Accepted
2023-04-14 16:05:49
Documents
5
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 PRE 14A preliminary_proxy_2023_a.htm PRE 14A 1645059
2 GRAPHIC img77935483_0.jpg GRAPHIC 32291
3 GRAPHIC img77935483_1.jpg GRAPHIC 31561
4 GRAPHIC img77935483_2.jpg GRAPHIC 533687
5 GRAPHIC img77935483_3.jpg GRAPHIC 457204
  Complete submission text file 0000950170-23-012876.txt   3098370
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38662 | Film No.: 23821152
SIC: 2836 Biological Products, (No Diagnostic Substances)